Recherche
-
Adherence to Direct Oral Anticoagulants in Patients With Non-Valvular Atrial Fibrillation: A Cross-National Comparison in Six European Countries (2008-2015)
(Frontiers in Pharmacology. vol. 12, pp. 682890, 2021-11-03)Article de revueLibre accès -
Use of IV Iron and Risk of Anaphylaxis: A Multinational Observational Post-Authorisation Safety Study in Europe
(Pharmacoepidemiology and Drug Safety, 2021-06-28)Article de revueLibre accès -
Epidemiology of metastatic castration-resistant prostate cancer: A first estimate of incidence and prevalence using the French nationwide healthcare database
(Cancer Epidemiology. vol. 69, pp. 101833, 2020)Article de revueLibre accès -
Agomelatine in Standard Medical Practice in Depressed Patients: Results of a 1-Year Multicentre Observational Study In France
(Clinical Drug Investigation. vol. 40, n° 11, pp. 1009-1020, 2020)Article de revueLibre accès -
Efficacy and Safety of TiNO-Coated Stents versus Drug-Eluting Stents in Acute Coronary Syndrome: Systematic Literature Review and Meta-Analysis.
(Biomedicines. vol. 10, n° 12, 2022-12-07)Article de revueLibre accès -
How Long Do Implanted Triclosan Sutures Inhibit Staphylococcus aureus in Surgical Conditions? A Pharmacological Model
(Pharmaceutics. vol. 14, n° 3, 2022-02-28)Article de revueLibre accès -
Incidence of direct oral anticoagulant use in patients with nonvalvular atrial fibrillation and characteristics of users in 6 European countries (2008-2015): A cross-national drug utilization study
(British Journal of Clinical Pharmacology. vol. 85, n° 11, pp. 2524-2539, 2019-11)Article de revueLibre accès -
Effectiveness and Safety of Rivaroxaban 15 or 20 mg Versus Vitamin K Antagonists in Nonvalvular Atrial Fibrillation
(Stroke. vol. 50, n° 9, pp. 2469-2476, 2019)Article de revueLibre accès -
The safety of agomelatine in standard medical practice in depressed patients: A 26-week international multicentre cohort study
(Human Psychopharmacology: Clinical and Experimental. pp. e2759, 2020-09-25)Article de revueLibre accès -
Baseline results from the European non-interventional Antipsychotic Long acTing injection in schizOphrenia (ALTO) study
(European psychiatry. vol. 52, pp. 85-94, 2018-08)Article de revueLibre accès